Evidence map›Paper›PMID 35938556›Full record

ArticleAlcoholism, clinical and experimental research2022

Tryptophan-kynurenine metabolism during acute alcohol withdrawal in patients with alcohol use disorder: The role of immune activation.

Sergei Mechtcheriakov, Gabriele V Gleissenthall, Simon Geisler, Kathrin Arnhard, Herbert Oberacher, Timo Schurr, Georg Kemmler, Christine Unterberger, Dietmar Fuchs

Open access · hybridAbstract read
In one paragraph

Article in Alcoholism, clinical and experimental research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Sergei MechtcheriakovUniversity Clinic of Psychiatry I, Department of Psychiatry, Psychotherapy, Psychosomatics, and Medical Psychology, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0000-0001-7634-3227
Gabriele V GleissenthallUniversity Clinic of Psychiatry I, Department of Psychiatry, Psychotherapy, Psychosomatics, and Medical Psychology, Medical University of Innsbruck, Innsbruck, Austria.
Simon GeislerInstitute of Biological Chemistry, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.
Kathrin ArnhardInstitute of Legal Medicine and Core Facility Metabolomics, Medical University of Innsbruck, Innsbruck, Austria.
Herbert OberacherInstitute of Legal Medicine and Core Facility Metabolomics, Medical University of Innsbruck, Innsbruck, Austria.
Timo SchurrUniversity Clinic of Psychiatry I, Department of Psychiatry, Psychotherapy, Psychosomatics, and Medical Psychology, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0000-0002-6757-7862
Georg KemmlerUniversity Clinic of Psychiatry I, Department of Psychiatry, Psychotherapy, Psychosomatics, and Medical Psychology, Medical University of Innsbruck, Innsbruck, Austria.
Christine UnterbergerUniversity Clinic of Psychiatry I, Department of Psychiatry, Psychotherapy, Psychosomatics, and Medical Psychology, Medical University of Innsbruck, Innsbruck, Austria.
Dietmar FuchsInstitute of Biological Chemistry, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.
Innsbruck Medical University · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecent research has suggested that excessive alcohol consumption in patients with alcohol use disorder (AUD) is associated with chronic immune activation, which affects the metabolism of the neurotransmitter precursor amino acid tryptophan (TRP) and contributes to the complex pathophysiology of AUD. Our study investigated possible immune-associated alterations of TRP to kynurenine (KYN) metabolism in patients with AUD during acute alcohol withdrawal.

methodsWe measured serum concentrations of TRP, KYN, quinolinic (QUIN), kynurenic acid (KYNA), and the immune activation marker neopterin (NEO) at the first, fifth and 10th day of alcohol withdrawal in patients with AUD, who attended a standardized in-patient treatment program and underwent a detailed clinical assessment.

resultsData from these individuals were compared to data from a reference control group (RCG). The primary outcome measures were the differences in serum concentrations of metabolites between AUD patients and RCG and correlations between NEO and metabolites of the tryptophan-kynurenine pathway. r = 0.695, p < 0.001) in the AUD group. Mixed models analysis showed that NEO concentrations were positively associated with QUIN but not with KYNA concentrations. Several behavioral symptoms correlated positively with QUIN concentrations and negatively with the KYNA/QUIN ratio.

conclusionsOur findings demonstrate that the changes in TRP catabolism in acute alcohol withdrawal resulting in increased KYN production could reflect the involvement of immune-associated activation of the enzyme indoleamine 2,3-dioxygenase, as NEO concentrations correlated with the KYN/TRP ratio. In addition, our data show that this low-grade immune activation may cause an imbalance in the production of neurotoxic and neuroprotective kynurenine metabolites in AUD.

Indexed as

AlcoholismSubstance Withdrawal SyndromeAlcohol DrinkingBiomarkersHumansIndoleamine-Pyrrole 2,3,-DioxygenaseKynurenic AcidKynurenineNeopterinQuinolinic AcidTryptophanBiomarkersIndoleamine-Pyrrole 2,3,-DioxygenaseKynurenic AcidKynurenineNeopterinQuinolinic AcidTryptophanalcohol use disorderimmune activationtryptophan-kynurenine metabolism

Identifiers

PMID35938556
PMCPMC9804431
OpenAlexW4292544707

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.